Image Quality of Virtual Noncontrast Images Derived from Dual-energy CT Angiography after Endovascular Aneurysm Repair JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY Sommer, W. H., Graser, A., Becker, C. R., Clevert, D. A., Reiser, M. F., Nikolaou, K., Johnson, T. R. 2010; 21 (3): 315-321

Abstract

To compare true and "virtual" noncontrast images derived from dual-energy CT examinations in patients after endovascular repair of aortic aneurysms.Seventy dual-energy CT examinations were performed on a dual-source CT scanner with a single-energy noncontrast scan and a dual-energy acquisition in venous phase. True and virtual noncontrast images were compared regarding image quality, calcifications in true noncontrast images, subtraction of calcification in virtual noncontrast images, and acceptance levels by two radiologists. Presence of endoleaks was assessed on venous-phase images and on virtual or true noncontrast images. In addition, the acceptance of color-coded images, in which iodine information is colored, was assessed. Possible dose reduction of a single-phase dual-energy examination protocol was compared with a standard biphasic examination protocol.Twenty-four endoleaks were detected and correctly classified with both approaches. Mean image quality was rated good for virtual noncontrast images (1.97 +/- 0.99) and excellent for true noncontrast images (1.16 +/- 0.37; P< .0001). Ninety-four percent of virtual noncontrast images were rated as diagnostic, and 80% of all true noncontrast images showed calcifications within the aneurysm. Subtraction of calcification in virtual noncontrast images was classified as none (30%), minimal (40%), moderate (24%), or severe (6%). Eighty-three percent of color-coded images were rated as fully diagnostic, 11% were accepted with restrictions, and 6% were nondiagnostic. Possible dose reduction of a single-phase dual-energy protocol, compared with a standard biphasic protocol, was 44%.Dual-energy CT makes a reliable detection of endoleaks feasible in a single acquisition. This provides a potential dose reduction for patients who have to undergo lifelong follow-up examinations after endovascular aneurysm repair.

View details for DOI 10.1016/j.jvir.2009.10.040

View details for Web of Science ID 000277367700001

View details for PubMedID 20097097